Related Experiment Video
Updated: Jun 24, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Susceptibility genes & modifiers for cardiac arrhythmias
1Leibniz Institute for Arteriosclerosis Research (LIFA), Molecular Cardiology, University of Münster, Germany. eric.schulze-bahr@ukmuenster.de <eric.schulze-bahr@ukmuenster.de>
This review explores how common genetic variations, or single nucleotide polymorphisms (SNPs), in cardiac ion channels may increase susceptibility to acquired cardiac arrhythmias like long-QT syndrome and fibrillation.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Cardiac arrhythmias without structural heart disease are either acquired or genetic.
- Acquired arrhythmias lack obvious genetic links, but common genetic variants (SNPs) in ion channels are frequent.
- The role of these natural variants as susceptibility markers for acquired arrhythmias is under investigation.
Purpose of the Study:
- To review genetic association and linkage studies on acquired cardiac arrhythmias.
- To explore the influence of single nucleotide polymorphisms (SNPs) in cardiac ion channels on acquired arrhythmias.
- To discuss the potential of genetic variants as susceptibility markers for acquired cardiac arrhythmias.
Main Methods:
- Review of genetic association studies.
- Review of linkage studies.
- Focus on drug-induced long-QT syndrome, atrial fibrillation, and ventricular fibrillation.
Main Results:
- Summarizes findings from genetic association and linkage studies.
- Highlights the potential role of SNPs in cardiac ion channels in acquired arrhythmias.
- Identifies genetic susceptibility markers for specific arrhythmia types.
Conclusions:
- Common genetic variants in cardiac ion channels may contribute to acquired arrhythmias.
- SNPs can serve as valuable genetic susceptibility markers.
- Further research is needed to fully elucidate the genetic basis of acquired cardiac arrhythmias.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...